Lawsuit for Investors in shares of Akorn, Inc. (NASDAQ: AKRX) announced by Shareholders Foundation

SAN DIEGO, June 04, 2018 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in Akorn, Inc. AKRX shares.

Investors who purchased shares of Akorn, Inc. AKRX in March 2017 or earlier and continue to hold NASDAQ: AKRX shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.



On March 8, 2018, a lawsuit was filed against Akorn, Inc. over alleged securities laws violations. The plaintiff claims that the defendants made materially false and/or misleading statements and/or failed to disclose that: Akorn's failure to comply with FDA data integrity requirements would jeopardize Fresenius's acquisition of Akorn, that Akorn lacked effective internal controls over financial reporting, and that as a result, Akorn's financial statements were materially false and misleading at all relevant times.



Those who purchased Akorn, Inc. AKRX shares should contact the Shareholders Foundation, Inc.



The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.



CONTACT:

Shareholders Foundation, Inc. 

Michael Daniels 

+1 (858) 779-1554 

mail@shareholdersfoundation.com 

3111 Camino Del Rio North 

Suite 423 

San Diego, CA 92108